These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 34692676)

  • 21. Integrated Analysis of the Immune Infiltrates and PD-L1 Expression of N6-Methyladenosine-Related Long Non-Coding RNAs in Colorectal Cancer.
    Jiang Z; Zhang Y; Chen K; Yang X; Liu J
    Int J Gen Med; 2021; 14():5017-5028. PubMed ID: 34511985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia.
    Zhang L; Ke W; Hu P; Li Z; Geng W; Guo Y; Song B; Jiang H; Zhang X; Wan C
    Front Genet; 2022; 13():804614. PubMed ID: 35615374
    [No Abstract]   [Full Text] [Related]  

  • 23. N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.
    Tu Z; Wu L; Wang P; Hu Q; Tao C; Li K; Huang K; Zhu X
    Front Cell Dev Biol; 2020; 8():642. PubMed ID: 32793593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer.
    Lv W; Wang Y; Zhao C; Tan Y; Xiong M; Yi Y; He X; Ren Y; Wu Y; Zhang Q
    Front Oncol; 2021; 11():745719. PubMed ID: 34722303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Analysis of N6-Methyladenosine-Related lncRNA Signature for Predicting Prognosis and Immune Cell Infiltration in Patients with Colorectal Cancer.
    Zhao Z; Yang YB; Li XY; Li XG; Chu XD; Lin ZB; Zhang YR; Guo YG; Ding H; Pan YL; Wang L; Pan JH
    Dis Markers; 2021; 2021():8686307. PubMed ID: 34745388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential Prognostic Value of a Seven m6A-Related LncRNAs Signature and the Correlative Immune Infiltration in Colon Adenocarcinoma.
    Chai XK; Qi W; Zou CY; He CX; Su M; Zhao DQ
    Front Genet; 2021; 12():774010. PubMed ID: 35003214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
    Wang JM; Li X; Yang P; Geng WB; Wang XY
    BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
    Wu ZY; Shi ZY
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
    Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
    Front Oncol; 2021; 11():663263. PubMed ID: 34123820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer.
    Feng ZH; Liang YP; Cen JJ; Yao HH; Lin HS; Li JY; Liang H; Wang Z; Deng Q; Cao JZ; Huang Y; Wei JH; Luo JH; Chen W; Chen ZH
    J Transl Med; 2022 Oct; 20(1):492. PubMed ID: 36309694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma.
    Zheng D; Yu L; Wei Z; Xia K; Guo W
    Front Genet; 2021; 12():805607. PubMed ID: 35186011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of N6-Methyladenosine-Related LncRNAs for Predicting Overall Survival and Clustering of a Potentially Novel Molecular Subtype of Breast Cancer.
    Zhong X; Li J; Wu X; Wu X; Hu L; Ding B; Qian L
    Front Oncol; 2021; 11():742944. PubMed ID: 34722294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Critical N6-Methyladenosine-Related Long Non-Coding RNAs and Their Correlations with Immune Checkpoints in Renal Clear Cell Carcinoma.
    Deng W; Wang G; Deng H; Yan Y; Zhu K; Chen R; Liu X; Chen L; Zeng T; Fu B
    Int J Gen Med; 2021; 14():9773-9787. PubMed ID: 34934351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of an N6-methyladenosine lncRNA- and immune cell infiltration-related prognostic model in colorectal cancer.
    Yu ZL; Zhu ZM
    Protoplasma; 2022 Jul; 259(4):1029-1045. PubMed ID: 34734333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and validation of N6-methyladenosine long non-coding RNAs signature of prognostic value for early biochemical recurrence of prostate cancer.
    Liu J; Zhang W; Wang J; Lv Z; Xia H; Zhang Z; Zhang Y; Wang J
    J Cancer Res Clin Oncol; 2023 May; 149(5):1969-1983. PubMed ID: 35731271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer.
    Zhang Y; Zhu B; He M; Cai Y; Ying X; Jiang C; Ji W; Zeng J
    Front Oncol; 2021; 11():710767. PubMed ID: 34458149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Analysis and Prognosis Prediction of N6-Methyladenosine-Related lncRNAs in Immune Microenvironment Infiltration of Gastric Cancer.
    Huang J; Chen W; Chen C; Jie Z; Xiao T
    Int J Gen Med; 2022; 15():2629-2643. PubMed ID: 35300127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of m6A RNA Methylation-Related lncRNAs in the Prognosis and Tumor Immune Microenvironment of Papillary Thyroid Carcinoma.
    Wang W; Shen C; Zhao Y; Sun B; Qiu X; Yin S; Chen J; Li X
    Front Cell Dev Biol; 2021; 9():719820. PubMed ID: 35047491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of m6A-Related lncRNAs for Prognosis Value and Response to Immune Checkpoint Inhibitors Therapy in Hepatocellular Carcinoma.
    Wang Y; Li N; Tian D; Zhou CW; Wang YH; Yang C; Zeng MS
    Cancer Manag Res; 2021; 13():6451-6471. PubMed ID: 34429653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.